Be part of the knowledge.

ReachMD is even better when
you join the community!
Registration is free and easy.

Register Now

Clinical Utility of HPV Genotyping and Primary Screening

How is hrHPV genotyping making a positive impact on patient management.
  • Sponsored by

  • Overview

    As evidence continues to accumulate about the risk of cervical cancer from persistent infection with high-risk types of human papillomavirus, particularly 16 and 18, professional associations have kept pace with updated guidance based on new data and testing methodologies.

    Join host, Dr. Matt Birnholz, as he interviews Dr. Lee Shulman, professor and chair of reproductive genetics at Northwestern University Feinberg School of Medicine, to discuss how hrHPV genotyping is included in standard screening algorithms, and genotyping of HPV 16 and 18 is making a positive impact on patient management in multiple ways.

Facebook Comments

You must be in to display playlists.

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.